Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)

Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review... PharmacoEconomics Open (2017) 1:255–263 https://doi.org/10.1007/s41669-017-0018-3 ORIGINAL RESEARCH ARTICLE Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR) 1 2 3 1,4 • • • Lisa Masucci Jaclyn Beca Mona Sabharwal Jeffrey S. Hoch Published online: 22 March 2017 The Author(s) 2017. This article is an open access publication Abstract reviews with a final funding recommendation (N = 34) Background Public drug plans are faced with increasingly were independently examined by two authors. Major difficult funding decisions. In Canada, the pan-Canadian methodological issues from each review were abstracted Oncology Drug Review (pCODR) makes funding recom- and grouped into nine main categories. Each issue was also mendations to the provincial and territorial drug plans categorized based on perception of the reviewer’s actions responsible for cancer drugs. Assessments of the economic to manage it. models submitted by pharmaceutical manufacturers are Results The most commonly reported issues involved publicly reported. costing (59% of reviews), time horizon (56%), and model Objectives The main objective of this research was to structure (36%). Several types of issues were identified that identify recurring methodological issues in economic usually could not be resolved, such as quality of clinical models submitted to pCODR for funding http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics - Open Springer Journals

Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR)

Loading next page...
 
/lp/springer_journal/methodological-issues-in-economic-evaluations-submitted-to-the-pan-L5j2YWlpNg
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes
ISSN
2509-4262
eISSN
2509-4254
D.O.I.
10.1007/s41669-017-0018-3
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics Open (2017) 1:255–263 https://doi.org/10.1007/s41669-017-0018-3 ORIGINAL RESEARCH ARTICLE Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR) 1 2 3 1,4 • • • Lisa Masucci Jaclyn Beca Mona Sabharwal Jeffrey S. Hoch Published online: 22 March 2017 The Author(s) 2017. This article is an open access publication Abstract reviews with a final funding recommendation (N = 34) Background Public drug plans are faced with increasingly were independently examined by two authors. Major difficult funding decisions. In Canada, the pan-Canadian methodological issues from each review were abstracted Oncology Drug Review (pCODR) makes funding recom- and grouped into nine main categories. Each issue was also mendations to the provincial and territorial drug plans categorized based on perception of the reviewer’s actions responsible for cancer drugs. Assessments of the economic to manage it. models submitted by pharmaceutical manufacturers are Results The most commonly reported issues involved publicly reported. costing (59% of reviews), time horizon (56%), and model Objectives The main objective of this research was to structure (36%). Several types of issues were identified that identify recurring methodological issues in economic usually could not be resolved, such as quality of clinical models submitted to pCODR for funding

Journal

PharmacoEconomics - OpenSpringer Journals

Published: Mar 22, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off